TOP
Nav Bar
  1. General Info
  2. Source Info
  3. Effects Info
  4. Reference
Phytochemical Details
01. General Information
Name Tetrandrine
PubChem CID 73078
Molecular Weight 622.7g/mol
Synonyms

(+)-tetrandrine, (+-)-tetrandrine, (-)-tetrandrine, (R,S)-Tetrandrine, (S,S)-tetrandrine, 6,6',7,12-tetramethoxy-2,2'-dimethyl-(1beta)-berbaman, d-tetrandrine, DL-tetrandrine, hanjisong, isotetrandrine, isotetrandrine dihydrochloride, L-tetrandrine, NSC-77037, phaeanthine, tetrandrine, tetrandrine dihydrochloride, tetrandrine dihydrochloride, (1beta)-isomer, tetrandrine, (1'beta)-isomer

Formula C₃₈H₄₂N₂O₆
SMILES CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC
InChI 1S/C38H42N2O6/c1-39-15-13-25-20-32(42-4)34-22-28(25)29(39)17-23-7-10-27(11-8-23)45-33-19-24(9-12-31(33)41-3)18-30-36-26(14-16-40(30)2)21-35(43-5)37(44-6)38(36)46-34/h7-12,19-22,29-30H,13-18H2,1-6H3/t29-,30-/m0/s1
InChIKey WVTKBKWTSCPRNU-KYJUHHDHSA-N
CAS Number 518-34-3
ChEMBL ID CHEMBL176045
ChEBI ID CHEBI:49
Herb ID HBIN046110
Drug Bank ID DB14066
KEGG ID C09654
Toxicity Organism Test Type Route(Dose)
rat LD50 intraperitoneal(165 mg/kg)
mouse LD50 intraperitoneal(254 mg/kg)
rat LD50 oral(322 mg/kg)
Structure 2D-img
Download
2D MOL 3D MOL
02. Source Information of Phytochemical
Stephania tetrandra Cold
Chineses Pinyin FenFangJi
Use Part Stephania tetrandra S. Moore
Habitat ZheJiang, AnHui, JiangXi, FuJian, GuangDong, GuangXi
Flavor Pungent; Bitter
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Ranunculales
    -->Family: Menispermaceae
     -->Genus: Stephania
      -->Species: Stephania tetrandra
03. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Drug(s) whose efficacy can be enhanced by this phytochemical
Hide/Show
Combination Pair ID: 16
Pair Name Tetrandrine, Sorafenib
Partner Name Sorafenib
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Phosphorylation AKT1 hsa207
Up-regulation Expression BAX hsa581
Up-regulation Expression BBC3 hsa27113
Down-regulation Expression BCL2 hsa596
Up-regulation Expression BCL2L11 KEGG ID N.A.
Down-regulation Expression BCL-xL hsa598
Down-regulation Expression BID hsa637
Up-regulation Expression CASP3 hsa836
Up-regulation Expression CASP8 hsa841
Up-regulation Expression CASP9 hsa842
Up-regulation Expression CYCS hsa54205
Down-regulation Expression MCL1 hsa4170
Up-regulation Cleavage PARP1 hsa142
In Vitro Model BEL-7402 Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_5492
HCT 116 Colon carcinoma Homo sapiens (Human) CVCL_0291
In Vivo Model All qualified mice were injected in the right flank with 2×10⁷ HCT116 cells suspended in 0.2 ml of PBS.
Result The antitumour activity of sorafenib plus tetrandrine may be attributed to the induction of the intrinsic apoptosis pathway through ROS/Akt signaling. This finding provides a novel approach that may broaden the clinical application of sorafenib.
Combination Pair ID: 620
Pair Name Tetrandrine, Cisplatin
Partner Name Cisplatin
Disease Info [ICD-11: 2B91] Colorectal cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Up-regulation Expression CASP3 hsa836
Down-regulation Expression CDH1 hsa999
Down-regulation Expression CTNNB1 hsa1499
Up-regulation Cleavage PARP1 hsa142
Down-regulation Expression VEGFA hsa7422
Down-regulation Expression WNT5A hsa7474
Down-regulation Expression WNT5B hsa81029
In Vitro Model OVCAR-3 High grade ovarian serous adenocarcinoma Homo sapiens (Human) CVCL_0465
Result Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo
04. Reference
No. Title Href
1 Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling. Br J Cancer. 2013 Jul 23;109(2):342-50. doi: 10.1038/bjc.2013.334. Click
2 Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo. Cancer Lett. 2011 May 1;304(1):21-32. doi: 10.1016/j.canlet.2011.01.022. Click
It has been 46874 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP